Your browser doesn't support javascript.
loading
To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.
Shi, Da; Beasock, Damian; Fessler, Adam; Szebeni, Janos; Ljubimova, Julia Y; Afonin, Kirill A; Dobrovolskaia, Marina A.
Afiliação
  • Shi D; Nanotechnology Characterization Lab, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, USA.
  • Beasock D; University of North Carolina Charlotte, Charlotte, NC, USA.
  • Fessler A; University of North Carolina Charlotte, Charlotte, NC, USA.
  • Szebeni J; Nanomedicine Research and Education Center, Institute of Translational Medicine, Semmelweis University, Budapest, Hungary; SeroScience LCC, Budapest, Hungary; Department of Nanobiotechnology and Regenerative Medicine, Faculty of Health, Miskolc University, Miskolc, Hungary.
  • Ljubimova JY; Terasaki Institute for Biomedical Innovation, Los Angeles, CA, USA.
  • Afonin KA; University of North Carolina Charlotte, Charlotte, NC, USA.
  • Dobrovolskaia MA; Nanotechnology Characterization Lab, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, USA. Electronic address: marina@mail.nih.gov.
Adv Drug Deliv Rev ; 180: 114079, 2022 01.
Article em En | MEDLINE | ID: mdl-34902516
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Portadores de Fármacos / Nanomedicina Limite: Animals / Humans Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Portadores de Fármacos / Nanomedicina Limite: Animals / Humans Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos